Eligibility by Province & Participating Rexall Pharmacies

Select Rexall Pharmacies are dispensing Paxlovid (available by prescription only) based on provincial guidelines

COVID-19 Antiviral: Paxlovid FAQs

Pfizer’s PAXLOVID is an oral anti-viral medication intended for use in COVID-19 positive patients with mild to moderate COVID-19 who:
- have received a positive result from a COVID- 19 test and
- who are at high risk of getting severe COVID-19, including hospitalization or death
PAXLOVID received Health Canada approval Monday, January 17, 2022, for use in patients 18+

PAXLOVID IS NOT approved for any of the following:
- To treat patients who are hospitalized due to severe or critical COVID-19.
- To prevent COVID-19.
- To be used for longer than 5 days in a row.
- For use in children and adolescents less than 18 years of age.
PAXLOVID consists of two medicines co-packaged together:
- nirmatrelvir (pink tablet)
- ritonavir (white tablet)
PAXLOVID must be started within 5 days of symptom onset and must be taken for 5 days in a row. Always take PAXLOVID as advised by your healthcare professional.
- You must always take the nirmatrelvir tablets at the same time as the ritonavir tablet.
- You can take PAXLOVID with or without food.
- Swallow the tablets whole. Do not break, chew or crush the tablets.
- Complete the entire 5-day treatment with PAXLOVID.
- Even if you feel better, do not stop taking PAXLOVID without talking to your healthcare professional first.
- Talk to your doctor if you do not feel better or if you feel worse after 5 days.
If you suffer from kidney or liver problems, talk to your healthcare professional as you may need a lower dose.